rs61734095

Variant summary

Our verdict is Benign. The variant received -17 ACMG points: 0P and 17B. BP6_Very_StrongBP7BS1BS2

The NM_001378609.3(OTOGL):​c.5598C>T​(p.Cys1866Cys) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00229 in 1,611,732 control chromosomes in the GnomAD database, including 34 homozygotes. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0090 ( 12 hom., cov: 32)
Exomes 𝑓: 0.0016 ( 22 hom. )

Consequence

OTOGL
NM_001378609.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 0.995

Publications

3 publications found
Variant links:
Genes affected
OTOGL (HGNC:26901): (otogelin like) The protein encoded by this gene belongs to the otogelin family. This gene is expressed in the inner ear of vertebrates with the highest level of expression seen at the embryonic stage and lowest in adult. Knockdown studies in zebrafish suggest that this gene is essential for normal inner ear function. Mutations in this gene are associated with autosomal recessive deafness. [provided by RefSeq, Dec 2012]
OTOGL Gene-Disease associations (from GenCC):
  • autosomal recessive nonsyndromic hearing loss 84B
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Laboratory for Molecular Medicine, G2P, Labcorp Genetics (formerly Invitae), PanelApp Australia
  • nonsyndromic genetic hearing loss
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • hearing loss, autosomal recessive
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -17 ACMG points.

BP6
Variant 12-80355740-C-T is Benign according to our data. Variant chr12-80355740-C-T is described in ClinVar as Benign. ClinVar VariationId is 226958.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.995 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00904 (1376/152202) while in subpopulation AFR AF = 0.0275 (1142/41522). AF 95% confidence interval is 0.0262. There are 12 homozygotes in GnomAd4. There are 654 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 12 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
OTOGLNM_001378609.3 linkc.5598C>T p.Cys1866Cys synonymous_variant Exon 47 of 59 ENST00000547103.7 NP_001365538.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
OTOGLENST00000547103.7 linkc.5598C>T p.Cys1866Cys synonymous_variant Exon 47 of 59 5 NM_001378609.3 ENSP00000447211.2 Q3ZCN5
OTOGLENST00000646859.1 linkc.5463C>T p.Cys1821Cys synonymous_variant Exon 51 of 63 ENSP00000496036.1 A0A2R8YF04
OTOGLENST00000298820.7 linkc.897C>T p.Cys299Cys synonymous_variant Exon 8 of 18 5 ENSP00000298820.3 H7BXL6

Frequencies

GnomAD3 genomes
AF:
0.00899
AC:
1367
AN:
152084
Hom.:
12
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0274
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00439
Gnomad ASJ
AF:
0.0147
Gnomad EAS
AF:
0.0150
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.0000944
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000353
Gnomad OTH
AF:
0.00574
GnomAD2 exomes
AF:
0.00393
AC:
963
AN:
244946
AF XY:
0.00325
show subpopulations
Gnomad AFR exome
AF:
0.0268
Gnomad AMR exome
AF:
0.00205
Gnomad ASJ exome
AF:
0.0124
Gnomad EAS exome
AF:
0.0152
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000548
Gnomad OTH exome
AF:
0.00301
GnomAD4 exome
AF:
0.00159
AC:
2320
AN:
1459530
Hom.:
22
Cov.:
31
AF XY:
0.00147
AC XY:
1065
AN XY:
725984
show subpopulations
African (AFR)
AF:
0.0273
AC:
912
AN:
33414
American (AMR)
AF:
0.00236
AC:
105
AN:
44496
Ashkenazi Jewish (ASJ)
AF:
0.0124
AC:
322
AN:
26040
East Asian (EAS)
AF:
0.00913
AC:
362
AN:
39640
South Asian (SAS)
AF:
0.000174
AC:
15
AN:
86120
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53364
Middle Eastern (MID)
AF:
0.00992
AC:
57
AN:
5746
European-Non Finnish (NFE)
AF:
0.000251
AC:
279
AN:
1110442
Other (OTH)
AF:
0.00445
AC:
268
AN:
60268
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
115
230
346
461
576
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
48
96
144
192
240
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00904
AC:
1376
AN:
152202
Hom.:
12
Cov.:
32
AF XY:
0.00879
AC XY:
654
AN XY:
74408
show subpopulations
African (AFR)
AF:
0.0275
AC:
1142
AN:
41522
American (AMR)
AF:
0.00438
AC:
67
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.0147
AC:
51
AN:
3468
East Asian (EAS)
AF:
0.0151
AC:
78
AN:
5176
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4826
European-Finnish (FIN)
AF:
0.0000944
AC:
1
AN:
10596
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000353
AC:
24
AN:
68010
Other (OTH)
AF:
0.00568
AC:
12
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
74
148
222
296
370
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00460
Hom.:
8
Bravo
AF:
0.0106
Asia WGS
AF:
0.00318
AC:
11
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

May 16, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 31, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:2
Oct 28, 2019
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 24, 2014
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Cys1857Cys in exon 46 of OTOGL: This variant is not expected to have clinical si gnificance because it does not alter an amino acid residue and is not located wi thin the splice consensus sequence. It has been identified in 2.4% (92/3756) of African American chromosomes from a broad population by the NHLBI Exome Sequenci ng Project (http://evs.gs.washington.edu/EVS; dbSNP rs61734095). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.47
CADD
Benign
5.6
DANN
Benign
0.79
PhyloP100
0.99
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.050
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs61734095; hg19: chr12-80749520; API